Association between Duffy antigen receptor for chemokines expression and levels of inflammation markers in sickle cell anemia patients

Clinical Immunology

Volumn 136, Issue 1, 2010, Pages 116-122

  Nebor, Danitza ^a   Durpes, Marie Claude ^a   Mougenel, Danielle ^b   Mukisi Mukaza, Martin ^a,b   Elion, Jacques ^a   Hardy Dessources, Marie Dominique ^a   Romana, Marc ^a  

^a UNIVERSITÉ DES ANTILLES ET DE LA GUYANE   (France)

^b CHU de Pointe a Pitre   (Guadeloupe)

Author keywords

Duffy antigen receptor for chemokines; Inflammation; Sickle cell disease

Indexed keywords

CHEMOKINE; DUFFY ANTIGEN RECEPTOR FOR CHEMOKINES; GLYCOPROTEIN; HYDROXYUREA; INTERLEUKIN 8; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE NECROSIS; CARIBBEAN ISLANDS; ERYTHROCYTE; FEMALE; GENE LOCUS; GENOTYPE; HUMAN; INFLAMMATION; KIDNEY DISEASE; LEG ULCER; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PATHOGENESIS; PATIENT SATISFACTION; PHENOTYPE; PREVALENCE; PRIAPISM; PRIORITY JOURNAL; SICKLE CELL ANEMIA;

ADULT; ALBUMINURIA; ANEMIA, SICKLE CELL; BLOOD CELL COUNT; CHEMOKINE CCL5; CREATININE; DUFFY BLOOD-GROUP SYSTEM; FEMALE; GENE FREQUENCY; GUADELOUPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INFLAMMATION; INTERLEUKIN-8; LEG ULCER; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; OSTEONECROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRIAPISM; RECEPTORS, CELL SURFACE; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77953290928     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.02.023     Document Type: Article

References (36)

1. Serjeant G.R. Sickle-cell disease. Lancet 350 (1997) 725-730
2. Bunn H.F. Pathogenesis and treatment of sickle cell disease. N. Engl. J. Med. 337 (1997) 762-769
3. Steinberg M., and Embury S. Natural history: overview. In: Embury S.H., Hebbel R.P., Mohandas N., and Steinberg M.H. (Eds). Sickle Cell Disease: Basic Principles and Practice (1994), Raven, New York 349-352
4. Alexander N., Higgs D., Dover G., and Serjeant G.R. Are there clinical phenotypes of homozygous sickle cell disease?. Br. J. Haematol. 126 (2004) 606-611
5. Platt O.S., Thorington B.D., Brambilla D.J., Milner P.F., Rosse W.F., Vichinsky E., and Kinney T.R. Pain in sickle cell disease. Rates and risk factors. N. Engl. J. Med. 325 (1991) 11-16
6. Platt O.S., Brambilla D.J., Rosse W.F., Milner P.F., Castro O., Steinberg M.H., and Klug P.P. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N. Engl. J. Med. 330 (1994) 1639-1644
7. Embury S.H., Dozy A.M., Miller J., Jr Davis J.R., Kleman K.M., Preisler H., Vichinsky E., Lande W.N., Lubin B.H., Kan Y.W., and Mentzer W.C. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia. N. Engl. J. Med. 306 (1982) 270-274
8. Powars D.R. Beta s-gene-cluster haplotypes in sickle cell anemia. Clinical and hematologic features. Hematol. Oncol. Clin. North Am. 5 (1991) 475-493
9. Balkaran B., Char G., Morris J.S., Thomas P.W., Serjeant B.E., and Serjeant G.R. Stroke in a cohort of patients with homozygous sickle cell disease. J. Pediatr. 120 (1992) 360-366
10. Duits A.J., Schnog J.B., Lard L.R., Saleh A.W., and Rojer R.A. Elevated IL-8 levels during sickle cell crisis. Eur. J. Haematol. 61 (1998) 302-305
11. Etienne-Julan M., Belloy M.S., Decastel M., Dougaparsad S., Ravion S., and Hardy-Dessources M.D. Childhood sickle cell crises: clinical severity, inflammatory markers and the role of interleukin-8. Haematology 89 (2004) 863-864
12. Platt O.S. Sickle cell anemia as an inflammatory disease. J. Clin. Invest. 106 (2000) 337-338
13. Kaul D.K., and Hebbel R.P. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J. Clin. Invest. 106 (2000) 411-420 Erratum in: J. Clin. Invest. 106 (2000) 715
14. Grimberg B.T., Udomsangpetch R., Xainli J., McHenry A., Panichakul T., Sattabongkot J., Cui L., Bockarie M., Chitnis C., Adams J., Zimmerman P.A., and King C.L. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PloS. Med. 4 (2007) e337
15. Gardner L., Patterson A.M., Ashton B.A., Stone M.A., and Middleton J. The human Duffy antigen binds selected inflammatory but not homeostatic chemokines. Biochem. Biophys. Res. Commun. 321 (2004) 306-312
16. Rot A. Contribution of Duffy antigen to chemokine function. Cytokine Growth. Factor. Rev. 16 (2005) 687-694
17. Hadley T.J., and Peiper S.C. From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood 89 (1997) 3077-3091
18. Chaudhuri A., Polyakova J., Zbrzezna V., and Pogo A.O. The coding sequence of Duffy blood group gene in humans and simians: restriction fragment length polymorphism, antibody and malarial parasite specificities, and expression in nonerythroid tissues in Duffy-negative individuals. Blood 85 (1995) 615-621
19. Parasol N., Reid M., Rios M., Castilho L., Harari I., and Kosower N.S. A novel mutation in the coding sequence of the FY*B allele of the Duffy chemokine receptor gene is associated with an altered erythrocyte phenotype. Blood 92 (1998) 2237-2243
20. Tournamille C., Le Van Kim C., Gane P., Le Pennec P.Y., Roubinet F., Babinet J., Cartron J.P., and Colin Y. Arg89Cys substitution results in very low membrane expression of the Duffy antigen/receptor for chemokines in Fy(x) individuals. Blood 92 (1998) 2147-2156 Erratum in: Blood. 95 (2000) 2753
21. Tournamille C., Colin Y., Cartron J.P., and Le Van Kim C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat. Genet. 10 (1995) 224-228
22. Darbonne W.C., Rice G.C., Mohler M.A., Apple T., Hébert C.A., Valente A.J., and Baker J.B. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J. Clin. Invest. 88 (1991) 1362-1369
23. Fukuma N., Akimitsu N., Hamamoto H., Kusuhara H., Sugiyama Y., and Sekimizu K. A role of the Duffy antigen for the maintenance of plasma chemokine concentrations. Biochem. Biophys. Res. Commun. 303 (2003) 137-139
24. Yazdanbakhsh K., Rios M., Storry J.R., Kosower N., Parasol N., Chaudhuri A., and Reid M.E. Molecular mechanisms that lead to reduced expression of Duffy antigens. Transfusion 40 (2000) 310-320
25. Castilho L., Rios M., Jr J., Pellegrino S.T.S., Costa F.F., and Reid M.E. A novel FY allele in Brazilians. Vox Sang. 87 (2004) 190-195
26. Frazer K.A., Ballinger D.G., Cox D.R., Hinds D.A., Stuve L.L., Gibbs R.A., Belmont J.W., Boudreau A., et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 449 (2007) 851-861
27. Afenyi-Annan A., Kail M., Combs M.R., Orringer E.P., Ashley-Koch A., and Telen M.J. Lack of Duffy antigen expression is associated with organ damage in patients with sickle cell disease. Transfusion 48 (2008) 917-924
28. Nalls M.A., Wilson J.G., Patterson N.J., Tandon A., Zmuda J.M., Huntsman S., Garcia M., Hu D., Li R., Beamer B.A., Patel K.V., Akylbekova E.L., Files J.C., Hardy C.L., Buxbaum S.G., Taylor H.A., Reich D., Harris T.B., and Ziv E. Admixture mapping of white cell count: genetic locus responsible for lower white blood cell count in the Health ABC and Jackson Heart studies. Am. J. Hum. Genet. 82 (2008) 81-87 Erratum in: Am. J. Hum. Genet. 82 (2008) 532
29. Reich D., Nalls M.A., Kao W.H., Akylbekova E.L., Tandon A., Patterson N., Mullikin J., Hsueh W.C., Cheng C.Y., Coresh J., Boerwinkle E., Li M., Waliszewska A., Neubauer J., Li R., Leak T.S., Ekunwe L., Files J.C., Hardy C.L., Zmuda J.M., Taylor H.A., Ziv E., Harris T.B., and Wilson J.G. Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene. PLoS. Genet. 5 (2009) e1000360
30. Schnog J.B., Keli S.O., Pieters R.A., Rojer R.A., and Duits A.J. Duffy phenotype does not influence the clinical severity of sickle cell disease. Clin. Immunol. 96 (2000) 264-268
31. Lee J.S., Wurfel M.M., Matute-Bello G., Frevert C.W., Rosengart M.R., Ranganathan M., Wong V.W., Holden T., Sutlief S., Richmond A., Peiper S., and Martin T.R. The Duffy antigen modifies systemic and local tissue chemokine responses following lipopolysaccharide stimulation. J. Immunol. 177 (2006) 8086-8094
32. Bonecchi R., Borroni E.M., Savino B., Buracchi C., Mantovani A., and Locati M. Non-signaling chemokine receptors: mechanism of action and role in vivo. J. Neuroimmunol. 198 (2008) 14-19
33. Nolan V.G., Adewoye A., Baldwin C., Wang L., Ma Q., Wyszynski D.F., Farrell J.J., Sebastiani P., Farrer L.A., and Steinberg M.H. Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway. Br. J. Haematol. 133 (2006) 570-578
34. Elliott L., Ashley-Koch A.E., De Castro L., Jonassaint J., Price J., Ataga K.I., Levesque M.C., Brice Weinberg J., Eckman J.R., Orringer E.P., Vance J.M., and Telen M.J. Genetic polymorphisms associated with priapism in sickle cell disease. Br. J. Haematol. 137 (2007) 262-267
35. Frenette P.S. Sickle cell vasoocclusion: heterotypic, multicellular aggregations driven by leukocyte adhesion. Microcirculation 11 (2004) 167-177
36. Abboud M.R., Taylor E.C., Habib D., Dantzler-Johnson T., Jackson S.M., Xu F., Laver J., and Ballas S.K. Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell disease. Br. J. Haematol. 111 (2000) 482-490